Alkem Laboratories on Tuesday said it has launched semaglutide in single-shot pre-filled syringes in India at a starting price of Rs 350, becoming the first company in the country to offer the popular diabetes and weight-management drug in the format.
The company said it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market semaglutide pre-filled syringes for the management of Type 2 diabetes mellitus and obesity as an adjunct to diet and exercise.